Beyond the surface. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
A modern landmark glaucoma trial and first-of-its-kind that provides surprising and useful outcomes for current practice and research. Can the visual field be preserved with an intraocular-pressure-lowering drug in patients with open-angle glaucoma? Dr Jennifer Fan Gaskin explores Latanoprost for open-angle glaucoma.
Jennifer Fan Gaskin is a Consultant Ophthalmologist at the Royal Victorian Eye and Ear Hospital and a Principal Investigator at the Centre for Eye Research Australia where she leads Ocular Fibrosis Research. In 2021 she was named a Superstar of STEM by Science and Technology Australia. She is a Director of Australian Vision Research (formerly known as the Ophthalmic Research Institute of Australia) and a board member of the Australian and New Zealand Glaucoma Society.